Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of the Gut–Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship
Naoko Ohtani, Norifumi Kawada
Hepatology Communications (2019) Vol. 3, Iss. 4, pp. 456-470
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
Jason Behary, Nadia Amorim, Xiaotao Jiang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 299
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Aliya Gulamhusein, Gideon M. Hirschfield
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 2, pp. 93-110
Closed Access | Times Cited: 232
Assessment of Nonalcoholic Fatty Liver Disease Symptoms and Gut–Liver Axis Status in Zebrafish after Exposure to Polystyrene Microplastics and Oxytetracycline, Alone and in Combination
Weishang Zhou, Wei Shi, Xueying Du, et al.
Environmental Health Perspectives (2023) Vol. 131, Iss. 4
Open Access | Times Cited: 63
Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease
Jiandong Yang, Yoshikazu Hirai, Kei Iida, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 40
Targeting the gut-liver-immune axis to treat cirrhosis
Thomas H. Tranah, Lindsey Edwards, Bernd Schnabl, et al.
Gut (2020) Vol. 70, Iss. 5, pp. 982-994
Closed Access | Times Cited: 124
<i>Lactobacillus</i> attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Na Young Lee, Min Jea Shin, Gi Soo Youn, et al.
Clinical and Molecular Hepatology (2020) Vol. 27, Iss. 1, pp. 110-124
Open Access | Times Cited: 94
Gut‐liver axis‐mediated mechanism of liver cancer: A special focus on the role of gut microbiota
Naoko Ohtani, Eiji Hara
Cancer Science (2021) Vol. 112, Iss. 11, pp. 4433-4443
Open Access | Times Cited: 76
Intestinal Bacterial Translocation Contributes to Diabetic Kidney Disease
Hoang Thuy Linh, Yasunori Iwata, Yasuko Senda, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 6, pp. 1105-1119
Open Access | Times Cited: 58
Immune tolerance of food is mediated by layers of CD4+ T cell dysfunction
Sung‐Wook Hong, P. Krueger, Kevin C. Osum, et al.
Nature (2022) Vol. 607, Iss. 7920, pp. 762-768
Open Access | Times Cited: 57
Intestinal microbiota of layer hens and its association with egg quality and safety
Dong Dai, Guanghai Qi, Jing Wang, et al.
Poultry Science (2022) Vol. 101, Iss. 9, pp. 102008-102008
Open Access | Times Cited: 49
Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations
Sulieman Ibraheem Shelash Al‐Hawary, Saade Abdalkareem Jasim, Mustafa M. Kadhim, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 4, pp. 1624-1639
Closed Access | Times Cited: 32
The Gut–Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases
Natalia Di Tommaso, Francesco Santopaolo, Antonio Gasbarrini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1470-1470
Open Access | Times Cited: 30
Gut‐liver axis: Potential mechanisms of action of food‐derived extracellular vesicles
Sitong Zhang, Qiyue Wang, Daniel En Liang Tan, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 6
Open Access | Times Cited: 13
Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets
Xinyu Li, Maozhang He, Xinrui Yi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26991-e26991
Open Access | Times Cited: 12
The role of microbiomes in gastrointestinal cancers: new insights
Aref Yarahmadi, Hamed Afkhami
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 8
Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
Jia Wang, Cynthia Rajani, Hong‐Xi Xu, et al.
Protein & Cell (2020) Vol. 12, Iss. 5, pp. 374-393
Open Access | Times Cited: 67
The Dysbiosis of Gut Microbiota Caused by Low-Dose Cadmium Aggravate the Injury of Mice Liver through Increasing Intestinal Permeability
Yehao Liu, Yuhui Li, Yuhong Xia, et al.
Microorganisms (2020) Vol. 8, Iss. 2, pp. 211-211
Open Access | Times Cited: 55
Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis
Ratika Sehgal, Mariana Ilha, Maija Vaittinen, et al.
Nutrients (2021) Vol. 13, Iss. 10, pp. 3509-3509
Open Access | Times Cited: 44
The Link between Gut Microbiota and Hepatic Encephalopathy
Sung‐Min Won, Ki‐Kwang Oh, Haripriya Gupta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8999-8999
Open Access | Times Cited: 35
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Yulin Zhang, Zhen-Jiao Li, Hong-Zhong Gou, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 35
Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code”
Raffaella Maria Gadaleta, Marica Cariello, Lucilla Crudele, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3212-3212
Open Access | Times Cited: 34
Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4
Yang Liu, Xin Zhang, Shuo Chen, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 3, pp. 522-539
Open Access | Times Cited: 28
Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD
Lingxuan An, Ulrich Wirth, Dominik Koch, et al.
Metabolites (2023) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 18
Using New Technologies to Analyze Gut Microbiota and Predict Cancer Risk
Mohammad Amin Hemmati, Marzieh Monemi, Shima Asli, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 1987-1987
Open Access | Times Cited: 5
Gut microbes associated with functional cure of chronic hepatitis B
Takashi Honda, Masatoshi Ishigami, Yoji Ishizu, et al.
Hepatology International (2025)
Open Access
Page 1 - Next Page

Scroll to top